ES2208334T3 - Derivados cetolida de 6-0 carbamato. - Google Patents

Derivados cetolida de 6-0 carbamato.

Info

Publication number
ES2208334T3
ES2208334T3 ES00936424T ES00936424T ES2208334T3 ES 2208334 T3 ES2208334 T3 ES 2208334T3 ES 00936424 T ES00936424 T ES 00936424T ES 00936424 T ES00936424 T ES 00936424T ES 2208334 T3 ES2208334 T3 ES 2208334T3
Authority
ES
Spain
Prior art keywords
group
compound
aryl
formula
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00936424T
Other languages
English (en)
Spanish (es)
Inventor
Ly T. Phan
Yat Sun Or
Zhenkun Ma
Yan Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2208334T3 publication Critical patent/ES2208334T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
ES00936424T 1999-06-07 2000-05-31 Derivados cetolida de 6-0 carbamato. Expired - Lifetime ES2208334T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32778499A 1999-06-07 1999-06-07
US327784 1999-06-07

Publications (1)

Publication Number Publication Date
ES2208334T3 true ES2208334T3 (es) 2004-06-16

Family

ID=23278051

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00936424T Expired - Lifetime ES2208334T3 (es) 1999-06-07 2000-05-31 Derivados cetolida de 6-0 carbamato.

Country Status (10)

Country Link
EP (1) EP1181300B1 (enExample)
JP (1) JP2003501439A (enExample)
AT (1) ATE250076T1 (enExample)
CA (1) CA2378671C (enExample)
DE (1) DE60005334T2 (enExample)
DK (1) DK1181300T3 (enExample)
ES (1) ES2208334T3 (enExample)
MX (1) MXPA01012661A (enExample)
PT (1) PT1181300E (enExample)
WO (1) WO2000075156A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) * 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
WO2003102010A1 (en) 2002-05-31 2003-12-11 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
SK285534B6 (sk) * 1996-09-04 2007-03-01 Abbott Laboratories 6-O-substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
AU4472797A (en) * 1996-10-31 1998-05-22 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
CA2290421C (en) * 1997-05-29 2007-05-08 Abbott Laboratories Multicyclic erythromycin derivatives
CN1259135A (zh) * 1997-06-11 2000-07-05 辉瑞产品公司 9－肟红霉素衍生物

Also Published As

Publication number Publication date
ATE250076T1 (de) 2003-10-15
JP2003501439A (ja) 2003-01-14
DK1181300T3 (da) 2004-01-26
WO2000075156A1 (en) 2000-12-14
EP1181300A1 (en) 2002-02-27
MXPA01012661A (es) 2002-07-22
DE60005334T2 (de) 2004-06-24
PT1181300E (pt) 2004-02-27
CA2378671A1 (en) 2000-12-14
DE60005334D1 (de) 2003-10-23
CA2378671C (en) 2007-04-24
EP1181300B1 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
ES2242983T3 (es) Cetolidos 6-0-sustituidos que tienen una actividad antibacteriana.
EP0638585B1 (en) 5-o-desosaminylerythronolide a derivative
ES2218604T3 (es) Derivados triciclicos de eritromicina.
PT1506214E (pt) Derivados de cetólido 6-11 bicíclicos
KR20050003454A (ko) 6,11 바이사이클릭 에리스로마이신 유도체
ES2244094T3 (es) Derivados de ketlido 2-halo-6-0-sustituidos.
ES2198766T3 (es) Derivados de eritromicina enlazados en las posiciones 6 y 11.
ES2203800T3 (es) Derivados de 3-descladinosa-2, 3-anhidroeritromicina.
WO2004011477A2 (en) 6,11-4-carbon bridged ketolides
MXPA04011204A (es) Derivados de cetoluros 6, 11-biciclicos.
US6420535B1 (en) 6-O-carbamate ketolide derivatives
ES2252784T3 (es) Compuestos a base de eritromicina 6-0 sustituida y tecnica de produccion.
ES2256030T3 (es) 9a-azalidas con actividad antibacteriana.
WO2003043642A1 (en) Novel tylosin derivatives having antibacterial activity
US20020019355A1 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
EP0262904A2 (en) Modifications of mycinose and 3-0-demethylmycinose in tylosintype macrolides
EP1181300B1 (en) 6-o-carbamate ketolide derivatives
JP2003501439A5 (enExample)
ES2306674T3 (es) Derivados cetolidos 6-o-alquil-2-nor-2-sustituidos.
ES2254389T3 (es) Agentes anti-infecciosos utiles contra cepas bacterianas resistntes a multiples farmacos.
ES2197472T3 (es) Derivados de eritromicina de ciclos multiples.
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives
MXPA00004227A (en) 6,11-bridged erythromycin derivatives